Total participants (n, %) | Â | 21 |
---|---|---|
Age, Median (Range) | Â | 31 (18-39) |
Gender | Male | 10 (48) |
Female | 11 (52) | |
Cancer Diagnosis | Testes | 3 (14) |
Leukemia | 3 (14) | |
Lymphoma | 6 (29) | |
Breast | 3 (14) | |
Sarcoma | 6 (29) | |
Previous Trial Involvement | Approached regarding CCT | 12 (57) |
Phase I | 2 (10) | |
Phase I/II | 3 (14) | |
Phase II | 3 (14) | |
Phase III | 4 (19) | |
Not Approached regarding CCT | 9 (43) | |
Enrolled on CCT | 10 (48) | |
Enrolled at time of diagnosis | 1 (5) | |
Enrolled at time of recurrence or during treatment for metastatic disease. | 9 (43) | |
English as first language | Yes | 18 (86) |
No | 3 (14) | |
Student and employment status | Currently Working | 6 (29) |
Working prior to diagnosis | 13 (62) | |
Currently at School | 3 (14) | |
Completed university degree | Yes | 14 (67) |
No | 7 (33) | |
Children | Yes | 9 (43) |
No | 12 (57) | |
Mean no. of dependent children | 1.3 | |
Relationship Status | Single | 4 (19) |
In a Relationship | 8 (38) | |
Married | 9 (43) |